Parkinson's Disease Trial, Recruiting NCT06482502 Sponsor: Emre Şenocak Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06482502
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Your Parkinson's disease is at a mild to moderate stage (scored 3 or below on a standard scale used to measure how advanced Parkinson's is)
  • You have not taken part in a formal rehabilitation program lasting at least 20 days in the last 6 months
  • You are able to fully move both arms upward and out to the sides without restriction

Who may not be able to join:

  • You have a serious heart condition, such as heart failure, an irregular heartbeat, or high blood pressure
  • You have any bone, joint, or muscle problem that affects your arms or shoulders
  • You have been diagnosed with a second neurological condition (a condition affecting the brain or nervous system) in addition to Parkinson's
  • You have a vision problem that is not fully corrected by wearing glasses or contact lenses
  • You have a cognitive condition (such as memory or thinking difficulties) that might make it hard to follow instructions from the research team
  • Your medication changed during the study period, including any changes in dose or type of medicine (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Murat Emirzeoğlu, PhD, Karadeniz Technical University

Phone: +90 553 569 56 92

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Emre Şenocak
Registry
ClinicalTrials.gov
Start date
20 May 2024
Est. completion
31 August 2024

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

6-Minute Pegboard and Ring Test; 6-Minute Pegboard and Ring Test; 6-Minute Pegboard and Ring Test; 6-Minute Pegboard and Ring Test; 30-Second Arm Curl Test; Weight Lifting Test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov